imatinib mesylate has been researched along with Hyperplasia, Reactive Lymphoid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clément, JF; Contentin, N; Courville, P; Jardin, F; Laquerriere, A; Lehembre, S; Lenain, P; Lenormand, B; Pouplin, S; Tilly, H | 1 |
1 other study(ies) available for imatinib mesylate and Hyperplasia, Reactive Lymphoid
Article | Year |
---|---|
Concomitant eosinophilia, fasciitis, and mycosis fungoides-like reaction with antinuclear autoantibodies in chronic myeloid leukaemia: role of a T-cell clone induced by imatinib.
Topics: Aged; Antibodies, Antinuclear; Antineoplastic Agents; Benzamides; Eosinophilia; Fasciitis; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mycosis Fungoides; Piperazines; Pseudolymphoma; Pyrimidines | 2005 |